The Valley Desk

NCT03107988 · Interventional trial

NANT 2015-02: A Phase 1 Study of Lorlatinib (PF-06463922)

Overall registry status Completed

Phase 1

Conditions Neuroblastoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov